Skip to content
Disclosery

SB INVESTMENT ADVISERS (UK) LTD

Follow

13F filer, CIK 1731509, LONDON, United Kingdom

SB INVESTMENT ADVISERS (UK) LTD reported $7,662,358,625 across 9 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001493152-26-038416

Period
2026-06-30
Reported value
$7.66B
Holdings
9
Top 10 weight
100%
New
0
Sold out
1

Part of the filer group SB INVESTMENT ADVISERS (UK) LTD

How groups are built

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ROIVexited-2,671,732-$74M
AURreduced-5,532,687-$37.7M
COMPreduced-500,000-$6.17M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001493152-26-038416, largest first. % of portfolio is the value over $7,662,358,625, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 349,542,259 shares; 2024Q4: 349,542,259 shares; 2025Q1: 349,542,259 shares; 2025Q2: 309,542,259 shares; 2025Q3: 289,542,259 shares; 2025Q4: 289,542,259 shares; 2026Q1: 289,542,259 shares; 2026Q2: 289,542,259 shares 289,542,259$5.03B65.64%0Timeline
GRABGRAB HOLDINGS LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 401,796,672 shares; 2024Q4: 401,796,672 shares; 2025Q1: 401,796,672 shares; 2025Q2: 401,796,672 shares; 2025Q3: 401,796,672 shares; 2025Q4: 401,796,672 shares; 2026Q1: 401,796,672 shares; 2026Q2: 401,796,672 shares 401,796,672$1.51B19.77%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 27,904,963 shares; 2024Q4: 27,904,963 shares; 2025Q1: 27,904,963 shares; 2025Q2: 27,904,963 shares; 2025Q3: 27,904,963 shares; 2025Q4: 27,904,963 shares; 2026Q1: 27,904,963 shares; 2026Q2: 27,904,963 shares 27,904,963$522M6.81%0Timeline
COMPCOMPASS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 68,070,273 shares; 2024Q4: 58,070,273 shares; 2025Q1: 48,070,273 shares; 2025Q2: 48,070,273 shares; 2025Q3: 44,761,137 shares; 2025Q4: 25,062,973 shares; 2026Q1: 22,004,702 shares; 2026Q2: 21,504,702 shares 21,504,702$265M3.46%-500,000Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 16,684,041 shares; 2024Q4: 16,684,041 shares; 2025Q1: 16,684,041 shares; 2025Q2: 16,684,041 shares; 2025Q3: 16,684,041 shares; 2025Q4: 13,116,977 shares; 2026Q1: 10,948,093 shares; 2026Q2: 10,948,093 shares 10,948,093$112M1.46%0Timeline
AURAURORA INNOVATION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 34,086,665 shares; 2024Q4: 25,997,126 shares; 2025Q1: 22,409,482 shares; 2025Q2: 19,811,760 shares; 2025Q3: 19,811,760 shares; 2025Q4: 19,811,760 shares; 2026Q1: 19,811,760 shares; 2026Q2: 14,279,073 shares 14,279,073$97.4M1.27%-5,532,687Timeline
NRGVENERGY VAULT HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 18,535,631 shares; 2024Q4: 18,535,631 shares; 2025Q1: 18,535,631 shares; 2025Q2: 18,535,631 shares; 2025Q3: 18,535,631 shares; 2025Q4: 18,535,631 shares; 2026Q1: 15,535,631 shares; 2026Q2: 15,535,631 shares 15,535,631$73.2M0.95%0Timeline
YMMFULL TRUCK ALLIANCE CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,165,391 shares; 2024Q4: 26,084,929 shares; 2025Q1: 7,038,625 shares; 2025Q2: 3,196,951 shares; 2025Q3: 10,125,112 shares; 2025Q4: 5,272,390 shares; 2026Q1: 5,272,390 shares; 2026Q2: 5,272,390 shares 5,272,390$42.8M0.56%0Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 610,729 shares; 2024Q4: 610,729 shares; 2025Q1: 610,729 shares; 2025Q2: 610,729 shares; 2025Q3: 610,729 shares; 2025Q4: 610,729 shares; 2026Q1: 610,729 shares; 2026Q2: 610,729 shares 610,729$6.05M0.08%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ROIVROIVANT SCIENCES LTD2,671,732$74Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001493152-26-038416 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001493152-26-038416 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001493152-26-023965 Quarter ended 2026-03-312026-05-18acceptance time not in the bulk data set
13F-HR 0001493152-26-007221 Quarter ended 2025-12-312026-02-18acceptance time not in the bulk data set
13F-HR 0001493152-25-023521 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR/A 0001493152-25-023523 Quarter ended 2025-06-302025-11-14acceptance time not in the bulk data set
13F-HR 0001641172-25-023674 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001641172-25-010504 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001493152-25-006623 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001493152-24-045287 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001493152-24-031809 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001493152-24-019427 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001493152-24-006311 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0000950123-23-010987 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0000950123-23-008230 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0000950123-23-005269 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000950123-23-002646 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001731509-22-000010 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001730859-22-000006 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001731509-22-000007 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001731509-22-000003 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR/A 0001731509-21-000008 Quarter ended 2021-09-302021-11-16acceptance time not in the bulk data set
13F-HR 0001731509-21-000005 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001731509-21-000004 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001731509-21-000003 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001731509-21-000001 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001731509-20-000009 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001731509-20-000008 Quarter ended 2020-06-302020-08-17acceptance time not in the bulk data set
13F-HR 0001731509-20-000005 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001731509-20-000002 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR/A 0001731509-19-000007 Quarter ended 2019-06-302019-12-09acceptance time not in the bulk data set
13F-HR 0001731509-19-000006 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001731509-19-000005 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0001731509-19-000003 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001731511-19-000003 Quarter ended 2018-12-312019-02-13acceptance time not in the bulk data set
13F-HR 0001731511-18-000009 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001731509-18-000009 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR/A 0001731509-18-000008 Quarter ended 2018-03-312018-06-01acceptance time not in the bulk data set
13F-HR 0001731509-18-000007 Quarter ended 2018-03-312018-05-16acceptance time not in the bulk data set
13F-HR 0001731509-18-000004 Quarter ended 2017-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001731511-18-000001 Quarter ended 2017-12-312018-02-15acceptance time not in the bulk data set